[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351105-105":59,"doc-detail-351105-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","rhoj-derived-peptide-promotes-chemosensitivity-by-inhibiting-glutamine-metabolism-in-gastric-cancer","RHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer","","Chemoresistance causes chemotherapy failure in gastric cancer, and dysregulated glutamine metabolism is increasingly recognized as a key driver. The study screens cisplatin-sensitive gastric cancer cells to derive a RHOJ-based peptide and evaluates its ability to act as a chemosensitizer. Proteomic and multiple mechanistic assays assess GLUL-mediated glutamine metabolism, oxidative stress, DNA damage, apoptosis, and drug-resistance reversal in vitro and in vivo.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/rhoj-derived-peptide-promotes-chemosensitivity-by-inhibiting-glutamine-metabolism-in-gastric-cancer/351105/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/rhoj-derived-peptide-promotes-chemosensitivity-by-inhibiting-glutamine-metabolism-in-gastric-cancer/351105.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why does chemoresistance undermine chemotherapy in gastric cancer?","Question",{"text":112,"@type":113},"Chemoresistance leads to chemotherapy failure in gastric cancer treatment, contributing to progression and poor outcomes. Dysregulated glutamine metabolism is identified as an important promoter of this resistance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the RHOJ-derived peptide identified and validated?",{"text":117,"@type":113},"Proteomic profiling was used to identify upregulated proteins in cisplatin-sensitive gastric cancer cells, from which peptides were derived for functional screening. A RHOJ-derived peptide was then validated as a candidate chemosensitizer using multiple experimental approaches.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism allows peptide 1 to restore cisplatin sensitivity?",{"text":121,"@type":113},"Peptide 1 is reported to bind glutamine synthetase (GLUL), inhibit glutamine production, increase ROS levels, induce DNA damage, and promote apoptosis in resistant cells, ultimately restoring cisplatin sensitivity in vitro and in vivo.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351105,1790210935,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Li et al. Journal of Translational Medicine (2026) 24:282  \n[https://doi.org/10.1186/s12967-026-07731-z](https://doi.org/10.1186/s12967-026-07731-z)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nRHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer  \nJian Li1*†, Huanqing Li1†, Fangzhou Ye1†, Jiayi Wang1†, Fan Li1, Songhua Bei1, Xiaohong Zhang1, Jun Jiang1* and Li Feng1*  \nAbstract  \nBackground Chemoresistance is a cause of chemotherapy failure in gastric cancer (GC) treatment. Recent studies have shown that the dysregulation of glutamine metabolism plays a pivotal role in promoting chemoresistance. While small-molecule inhibitors targeting glutamine metabolism have been investigated, peptide-based compounds have attracted increasing attention because of their high specificity and low toxicity. Endogenous or rationally designed peptides have shown potential for inducing apoptosis, disrupting cancer-related signaling pathways, and overcoming drug resistance in various cancers. However, the potential of functional peptides to target glutamine metabolism and reverse drug resistance in the context of GC has not been thoroughly explored.  \nMethods We performed proteomic profiling to identify upregulated proteins in cisplatin-sensitive GC cells, from which peptides were derived for functional screening. A RHOJ-derived peptide (peptide 1) was identified and validated as a candidate chemosensitizer. Untargeted metabolomics, flow cytometry, molecular docking, molecular dynamics simulations, fluorescence imaging, and a subcutaneous xenograft model were used to investigate the mechanism through which peptide 1 modulates GLUL-mediated glutamine metabolism and reverses cisplatin resistance.  \nResults In this study, we found that glutamine metabolism was enhanced in cisplatin-resistant GC cells and that a peptide which derived from RHOJ (peptide 1) increased the sensitivity of resistant cells to chemotherapy. Molecular docking revealed that this peptide could bind to glutamine synthetase (GLUL), a key enzyme in the glutamine metabolism pathway. Mechanistically, peptide 1 inhibited glutamine production, increased ROS levels, induced DNA damage, and promoted apoptosis in resistant cells, ultimately restoring cisplatin sensitivity both in vitro and in vivo.  \n†Jian Li, Huanqing Li, Fangzhou Ye and Jiayi Wang contributed equally to this work.  \n*Correspondence:  \nJian Li [jianli21@m.fudan.edu.cn](jianli21@m.fudan.edu.cn)[ ](jianli21@m.fudan.edu.cn)Jun Jiang [jun_jiang@fudan.edu.cn](jun_jiang@fudan.edu.cn)[ ](jun_jiang@fudan.edu.cn)Li Feng [feng_li@fudan.edu.cn](feng_li@fudan.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nLi et al. Journal of Translational Medicine (2026) 24:282 Page 2 of 24  \nConclusions Our study demonstrated","cbCaiaACOBTQfZOw","https://ap.wps.com/l/cbCaiaACOBTQfZOw","pdf",4728981,24,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"Why does chemoresistance undermine chemotherapy in gastric cancer?\",\"answer\":\"Chemoresistance leads to chemotherapy failure in gastric cancer treatment, contributing to progression and poor outcomes. Dysregulated glutamine metabolism is identified as an important promoter of this resistance.\"},{\"question\":\"How was the RHOJ-derived peptide identified and validated?\",\"answer\":\"Proteomic profiling was used to identify upregulated proteins in cisplatin-sensitive gastric cancer cells, from which peptides were derived for functional screening. A RHOJ-derived peptide was then validated as a candidate chemosensitizer using multiple experimental approaches.\"},{\"question\":\"What mechanism allows peptide 1 to restore cisplatin sensitivity?\",\"answer\":\"Peptide 1 is reported to bind glutamine synthetase (GLUL), inhibit glutamine production, increase ROS levels, induce DNA damage, and promote apoptosis in resistant cells, ultimately restoring cisplatin sensitivity in vitro and in vivo.\"}]","RHOJ derived peptide promotes chemosensitivity by inhibiting glutamine metabolism in gastric cancer | PDF",1790092644,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0638bb20460d3969b03963740987fefa.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60c0db610f57f6d97589816ee121cbc8.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3ca7dd0930c262883128f694f683279.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/252e9266cad61ca61b52cbc1a74c4c8f.webp",980,1306]